<< GENZL has just started to ramp up sales and it has a huge pipeline. >>
I have a full position in GENZL. But, I don't agree about their "huge" pipeline.
They have Epicel, which is a slow growth skin growing product for burns.
They have TGF-B2, which is a product for diabetic ulcers, in Phase II, for which they are looking for a funding partner.
They have their Neurocell product for Parkinsons and Huntington's disease, in Phase II, for which they are looking for a funding partner.
But, that's all. They are also looking into other partnerships based on their Carticel and Epicel technology, but nothing has materialized, yet.
I feel that their business plan for Carticel is just getting into high gear, and is going to result in a very profitable business, but I don't see the "huge" pipeline.
Regards, Bob
|
